| Purity (HPLC) | ≥99% HPLC |
|---|---|
| CAS Number | 2381089-83-2 |
| Molecular Formula | C221H342N46O68 |
| Molecular Weight | 4731.3 g/mol |
| Sequence | 39-aa synthetic triple agonist (GLP-1R / GIPR / GCGR) |
| Form | Lyophilized |
| Storage | Store dry at −20°C; 2–8°C after reconstitution |

Retatrutide (GLP-3)
46.41€ – 102.21€
plus shipping
GLP-1 / GIP / glucagon triple agonist (“GLP-3”). Lyophilized, ≥99% HPLC. Certificate of Analysis available.
- Purity
- ≥99% HPLC
- CAS
- 2381089-83-2
- Formula
- C221H342N46O68
- Mol. weight
- 4731.3 g/mol
- Form
- Lyophilized
- Storage
- Store dry at −20°C; 2–8°C after reconstitution
Certificate of Analysis
Every batch is independently tested by HPLC (purity), LC-MS (identity) and screened for endotoxins and heavy metals.
COA for this batch available on request.
Overview
Retatrutide is a synthetic, single-peptide triple agonist acting at the GLP-1, GIP and glucagon receptors — the receptor profile researchers informally refer to as “GLP-3”. It is supplied lyophilized for in-vitro receptor and metabolic-signaling studies.
Research background
Published preclinical and clinical-research literature has examined triple-agonist pharmacology at GLP-1R/GIPR/GCGR and its effects on energy-expenditure and lipid-metabolism endpoints in laboratory models.
All statements describe published third-party in-vitro / preclinical research only. Products are supplied strictly for laboratory research use — not for human or veterinary use.
| Size | 10 mg, 20 mg, 30 mg |
|---|



Reviews
There are no reviews yet.